The International Prognostic Index-Chronic Lymphocytic Leukemia (IPI-CLL) was used to assess risk stratification according to a number of prognostic markers, including age, B-CLL stage, IGHV status, 17p13 deletion, and β2 microglobulin level [25]. Here, HLA-G is linked to B-cell chronic lymphocytic leukemia.